Objects
McKetin, Rebecca, Gardner, Jonathan, Baker, Amanda L., Dawe, Sharon, Ali, Robert, Voce, Alexandra, Leach, Liana S., Lubman, Dan I.. Elsevier; 2016. Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users.
Wodak, Alex D., Ali, Robert, Henry, David, Sansom, Lloyd. Australasian Medical Publishing Company; 2008. Ensuring the safety of new medications and devices: are naltrexone implants safe? (editorial).
Farrell, Michael, Shahbazi, Jeyran, Byrne, Marianne, Grebely, Jason, Lintzeris, Nicholas, Chambers, Mark, Larance, Briony, Ali, Robert, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Nicholas, Thomas, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa. Elsevier; 2022. Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence.
McKetin, Rebecca, Najman, Jake M., Baker, Amanda L., Lubman, Dan I., Dawe, Sharon, Ali, Robert, Lee, Nicole K., Mattick, Richard P., Mamun, Abdullah. Wiley-Blackwell Publishing; 2012. Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES).
McKetin, Rebecca, Boden, Joseph M., Foulds, James A., Najman, Jake M., Ali, Robert, Degenhardt, Louisa, Baker, Amanda L., Ross, Joanne, Farrell, Michael, Weatherburn, Don. Elsevier; 2020. The contribution of methamphetamine use to crime: evidence from Australian longitudinal data.
McKetin, Rebecca, Voce, Alexandra, Burns, Richard, Ali, Robert, Lubman, Dan I., Baker, Amanda L., Castle, David J.. Frontiers Research Foundation; 2018. Latent psychotic symptom profiles amongst people who use methamphetamine: what do they tell us about existing diagnostic categories?.
Farrell, Michael, Shahbazi, Jeyran, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa, Chambers, Mark, Byrne, Marianne, Gholami, Jaleh, Zahra, Emma, Grebely, Jason, Lintzeris, Nicholas, Larance, Briony, Ali, Robert. Elsevier; 2024. 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.